Could one daily aspirin pill fail to protect these patients from heart attacks?
NCT ID NCT04912505
Summary
This study investigated whether a standard daily low-dose aspirin pill is enough to prevent blood clots in adults who have both a rare bleeding disorder (immune thrombocytopenia) and heart disease. Researchers measured how well aspirin worked in the body 24 hours after a dose in four patients. The goal was to see if the fast turnover of platelets in this condition makes once-daily aspirin insufficient for stable protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PURPURA, THROMBOCYTOPENIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toulouse Hospital
Toulouse, France
Conditions
Explore the condition pages connected to this study.